$9.77 4.9%
ARQT Stock Price vs. AI Score (Last 150 days)
Data gathered: July 18

AI Score



Sign up to see AI score

Brand Score Sign up
Employment Score Sign up
User Growth Score Sign up
Fundamental Score Sign up

About Arcutis Biotherapeutics

Arcutis Biotherapeutics, Inc., a biopharmaceutical company, focuses on developing and commercializing treatments for dermatological diseases.


Arcutis Biotherapeutics
Price $9.77
Target Price Sign up
Volume 2,080,000
Market Cap $1.24B
Year Range $1.84 - $12.53
Dividend Yield 0%
Revenue per Employee $339,825
Industry Biotechnology

In the news


Financial performance View All

Revenue Cost of Revenue Gross Profit Net Income ebitda EPS
Q1 '2450M58M-8.7M-35M-27M-0.320
Q4 '235.8M58M-52M-66M-58M-0.720
Q3 '2331M236M-205M-45M154M-0.730
Q2 '235.2M234M-229M-71M124M-1.160
Q1 '232.8M43M-47M-80M-73M-1.310

Insider Transactions View All

Welgus Howard G. filed to sell 180,339 shares at $9.3.
July 2 '24
Welgus Howard G. filed to sell 176,658 shares at $8.
June 6 '24
Welgus Howard G. filed to sell 170,200 shares at $8.
June 6 '24
Burnett Patrick filed to sell 209,793 shares at $8.8.
May 31 '24
Burnett Patrick filed to sell 209,793 shares at $8.7.
May 31 '24

Congress Trading View All

Politician Filing Date Type Size
Joshua Gottheimer
Democrat
Oct 15, 23 Sell $1K - $15K
Joshua Gottheimer
Democrat
May 19, 23 Buy $1K - $15K
Joshua Gottheimer
Democrat
Jul 22, 22 Buy $1K - $15K

What is the Market Cap of Arcutis Biotherapeutics?

The Market Cap of Arcutis Biotherapeutics is $1.24B.

How Many People Work at Arcutis Biotherapeutics?

As of our latest update, Arcutis Biotherapeutics employed approximately 268 people worldwide. However, it's important to note that Arcutis Biotherapeutics' workforce size can fluctuate due to the company's growth, restructuring, or strategic shifts, so the current number of employees may be different.

What is Arcutis Biotherapeutics' revenue per employee?

$339,825. To calculate Arcutis Biotherapeutics' revenue per employee, we divide the company's total revenue in the last 4 quarters by its total number of employees.

What is the current stock price of Arcutis Biotherapeutics?

Currently, the price of one share of Arcutis Biotherapeutics stock is $9.77.

How can I analyze the ARQT stock price chart for investment decisions?

The ARQT stock price chart above provides a comprehensive visual representation of Arcutis Biotherapeutics' stock performance over time. Investors can use this chart to identify patterns, trends, and potential support or resistance levels. By examining historical data and recent price movements, investors can make more informed decisions regarding buying, holding, or selling Arcutis Biotherapeutics shares. Our platform offers an up-to-date ARQT stock price chart, along with technical data analysis and alternative data insights.

Does ARQT offer dividends to its shareholders?

As of our latest update, Arcutis Biotherapeutics (ARQT) does not offer dividends to its shareholders. Investors interested in Arcutis Biotherapeutics should consider the potential for capital appreciation as the primary return on investment, rather than expecting dividend payouts.

What are some of the similar stocks of Arcutis Biotherapeutics?

Some of the similar stocks of Arcutis Biotherapeutics are Amgen, Gilead Sciences, Catalyst Pharmaceuticals, Inovio Pharmaceuticals, and Anavex Life Sciences.

.
The analytics provided are estimates and not a substitute for professional advice. All investments involve risks, including possible capital loss.
About Us

AltIndex revolutionizes investing with advanced alternative data analytics, smart insights, and stock alerts, presented in an easy-to-use dashboard powered by comprehensive company data from across the internet.



Legal Disclaimer
The information provided by AltIndex is solely for informational purposes and not a substitute for professional financial advice. Investing in financial markets carries inherent risks, and past performance doesn't guarantee future results. It's crucial to do your research, consult with financial experts, and align your financial objectives and risk tolerance before investing. AltIndex creators and operators are not liable for any financial losses incurred from using this information. Users should exercise caution, seek professional advice, and be prepared for the risks involved in trading and investing in financial assets, only investing what they can afford to lose. The information in this application, derived from publicly available data, is believed to be reliable but may not always be accurate or current. Users should verify information independently and not solely rely on this application for financial decisions. By using AltIndex, you acknowledge that it doesn't offer financial advice and agree to consult a qualified financial advisor before making investment decisions.

© 2024 AltIndex. All rights reserved.